SHS sells its stake in Swiss evitria AG, a world market leader in the production of customised antibodies
Atlas Antibodies acquires evitria Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression. Since its inception in 2010, evitria has been singularly […]
Artificial intelligence will revolutionise the healthcare sector in this decade. With smart concepts and innovative healthtech products, we can make the healthcare system more efficient and effective.
Healthcare investor SHS sells stake in Crystal GmbH, a high-tech company in the field of crystal processing with medical technology application
The Tübingen-based healthcare investor SHS has accompanied Crystal GmbH on its growth path with its know-how, the required capital and extensive networks. Crystal’s optical components are used, for example, in the medical technology industry in respirators and as diffusion-bonded laser crystals in the manufacture of laser systems. The new investor Silver Investment Partners (SIP) will […]
For the future performance and efficiency in medical care, the degree of digitalisation will be decisive, in addition to the qualified specialist staff.
German healthcare investor SHS and Dutch Rubio Impact Ventures invest €5 million in Incision for international expansion and new services for its surgical platform
Incision is rapidly expanding its platform for surgical performance and online training The German SHS Gesellschaft für Beteiligungsmanagement mbH and investor Rubio Impact Ventures from Amsterdam provide 5 million euros for the expansion of Incision Group’s international business Operating room staff and surgical residents from over 200 hospitals in more than 18 countries now use […]
Corona hits everyone, including the healthcare industry – which is essential to a functioning healthcare system.
ntv reported in an exciting TV report about Mental Health Apps with focus on the DiGa of the SHS portfolio company Selfapy GmbH. It shows that digital therapies are increasingly arriving in mainstream care. Especially in the pandemic, low-threshold digital solutions are a great added value for patients.
Unquote reports on the sale of homecare specialist Medigroba to the Löwenstein Group. The deal is SHS’s second exit of 2021; the GP sold its stake in Crystal LaserSystems to Silver Investment Partners in March 2021. SHS expects to launch fundraising for its next fund later in 2021.
In the course of a successful succession arrangement, Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH sells its shares in medigroba GmbH to Löwenstein Group With SHS as majority shareholder, medigroba has more than doubled revenue and tripled EBITDA in the last four and a half years Due to the continuing trend towards outpatient care, the medium-sized […]
ESG, SRI, impact investing: when did this start, and what is its importance in the healthcare sector?